TY - JOUR AU - Turesson, C. AU - O'Fallon, W. M. AU - Crowson, C. S. AU - Gabriel, S. E. AU - Matteson, E. L. PY - 2002 DA - 2002// TI - Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis JO - J Rheumatol VL - 29 ID - Turesson2002 ER - TY - JOUR AU - Scott, D. L. AU - Wolfe, F. AU - Huizinga, T. W. PY - 2010 DA - 2010// TI - Rheumatoid arthritis JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60826-4 DO - 10.1016/S0140-6736(10)60826-4 ID - Scott2010 ER - TY - JOUR AU - Scott, D. L. AU - Smith, C. AU - Kingsley, G. PY - 2003 DA - 2003// TI - Joint damage and disability in rheumatoid arthritis: an updated systematic review JO - Clin Exp Rheumatol VL - 21 ID - Scott2003 ER - TY - JOUR AU - Smolen, J. S. AU - Landewe, R. AU - Breedveld, F. C. AU - Dougados, M. AU - Emery, P. AU - Gaujoux-Viala, C. AU - Gorter, S. AU - Knevel, R. AU - Nam, J. AU - Schoels, M. AU - Aletaha, D. AU - Buch, M. AU - Gossec, L. AU - Huizinga, T. AU - Bijlsma, J. W. AU - Burmester, G. AU - Combe, B. AU - Cutolo, M. AU - Gabay, C. AU - Gomez-Reino, J. AU - Kouloumas, M. AU - Kvien, T. K. AU - Martin-Mola, E. AU - McInnes, I. AU - Pavelka, K. AU - van, R. P. AU - Scholte, M. AU - Scott, D. L. AU - Sokka, T. AU - Valesini, G. AU - van, V. R. AU - Winthrop, K. L. AU - Wong, J. AU - Zink, A. AU - van der, H. D. PY - 2010 DA - 2010// TI - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.126532 DO - 10.1136/ard.2009.126532 ID - Smolen2010 ER - TY - JOUR AU - Luqmani, R. AU - Hennell, S. AU - Estrach, C. AU - Basher, D. AU - Birrell, F. AU - Bosworth, A. AU - Burke, F. AU - Callaghan, C. AU - Candal-Couto, J. AU - Fokke, C. AU - Goodson, N. AU - Homer, D. AU - Jackman, J. AU - Jeffreson, P. AU - Oliver, S. AU - Reed, M. AU - Sanz, L. AU - Stableford, Z. AU - Taylor, P. AU - Todd, N. AU - Warburton, L. AU - Washbrook, C. AU - Wilkinson, M. PY - 2009 DA - 2009// TI - British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years) JO - Rheumatology (Oxford) VL - 48 UR - https://doi.org/10.1093/rheumatology/ken450a DO - 10.1093/rheumatology/ken450a ID - Luqmani2009 ER - TY - JOUR AU - Luqmani, R. AU - Hennell, S. AU - Estrach, C. AU - Birrell, F. AU - Bosworth, A. AU - Davenport, G. AU - Fokke, C. AU - Goodson, N. AU - Jeffreson, P. AU - Lamb, E. AU - Mohammed, R. AU - Oliver, S. AU - Stableford, Z. AU - Walsh, D. AU - Washbrook, C. AU - Webb, F. PY - 2006 DA - 2006// TI - British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years) JO - Rheumatology (Oxford) VL - 45 UR - https://doi.org/10.1093/rheumatology/kel215a DO - 10.1093/rheumatology/kel215a ID - Luqmani2006 ER - TY - STD TI - Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002, 46: 328-346. ID - ref7 ER - TY - JOUR AU - Meyer, O. AU - de, B. M. AU - Berthelot, J. M. AU - Cantagrel, A. AU - Combe, B. AU - Fautrel, B. AU - Flipo, R. M. AU - Liote, F. AU - Maillefert, J. F. AU - Saraux, A. AU - Wendling, D. AU - Guillemin, F. AU - X Le, L. PY - 2007 DA - 2007// TI - Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy JO - Joint Bone Spine VL - 74 UR - https://doi.org/10.1016/j.jbspin.2006.05.008 DO - 10.1016/j.jbspin.2006.05.008 ID - Meyer2007 ER - TY - JOUR AU - DeWitt, E. M. AU - Lin, L. AU - Glick, H. A. AU - Anstrom, K. J. AU - Schulman, K. A. AU - Reed, S. D. PY - 2009 DA - 2009// TI - Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank JO - Clin Ther VL - 31 UR - https://doi.org/10.1016/j.clinthera.2009.08.020 DO - 10.1016/j.clinthera.2009.08.020 ID - DeWitt2009 ER - TY - JOUR AU - Yazici, Y. AU - Shi, N. AU - John, A. PY - 2008 DA - 2008// TI - Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy JO - Bull NYU Hosp Jt Dis VL - 66 ID - Yazici2008 ER - TY - JOUR AU - Grijalva, C. G. AU - Chung, C. P. AU - Stein, C. M. AU - Mitchel, E. F. AU - Griffin, M. R. PY - 2008 DA - 2008// TI - Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population JO - Rheumatology (Oxford) VL - 47 UR - https://doi.org/10.1093/rheumatology/ken193 DO - 10.1093/rheumatology/ken193 ID - Grijalva2008 ER - TY - BOOK PY - 2009 DA - 2009// TI - NICE clinical guideline 79: Rheumatoid arthritis: the management of rheumatoid arthritis in adults. London ID - ref12 ER - TY - STD TI - BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy. [http://www.rheumatology.org.uk/includes/documents/cm_docs/2010/r/2_ra_guidelines_on_eligibility_criteria_for_the_first_biological_therapy.pdf] UR - http://www.rheumatology.org.uk/includes/documents/cm_docs/2010/r/2_ra_guidelines_on_eligibility_criteria_for_the_first_biological_therapy.pdf ID - ref13 ER - TY - JOUR AU - Gibofsky, A. AU - Palmer, W. R. AU - Goldman, J. A. AU - Lautzenheiser, R. L. AU - Markenson, J. A. AU - Weaver, A. AU - Schiff, M. H. AU - Keystone, E. C. AU - Paulus, H. E. AU - Harrison, M. J. AU - Whitmore, J. B. AU - Leff, J. A. PY - 2006 DA - 2006// TI - Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study JO - Curr Med Res Opin VL - 22 UR - https://doi.org/10.1185/030079906X80341 DO - 10.1185/030079906X80341 ID - Gibofsky2006 ER - TY - STD TI - Health insurance portability and accountability act of 1996. Public law 104-191, 104th Congress. [http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf] UR - http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf ID - ref15 ER - TY - JOUR AU - Quan, H. AU - Sundararajan, V. AU - Halfon, P. AU - Fong, A. AU - Burnand, B. AU - Luthi, J. C. AU - Saunders, L. D. AU - Beck, C. A. AU - Feasby, T. E. AU - Ghali, W. A. PY - 2005 DA - 2005// TI - Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data JO - Med Care VL - 43 UR - https://doi.org/10.1097/01.mlr.0000182534.19832.83 DO - 10.1097/01.mlr.0000182534.19832.83 ID - Quan2005 ER - TY - JOUR AU - Gilbert, T. D. AU - Smith, D. AU - Ollendorf, D. A. PY - 2004 DA - 2004// TI - Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study JO - BMC Musculoskelet Disord VL - 5 UR - https://doi.org/10.1186/1471-2474-5-36 DO - 10.1186/1471-2474-5-36 ID - Gilbert2004 ER - TY - CHAP PY - 2009 DA - 2009// BT - Remicade prescribing information PB - Malvern CY - PA ID - ref18 ER - TY - CHAP PY - 2009 DA - 2009// BT - Orencia Prescribing Information PB - Princeton CY - NJ ID - ref19 ER - TY - CHAP PY - 2010 DA - 2010// BT - Rituxan Prescribing Informatino PB - South San Francisco CY - CA ID - ref20 ER - TY - JOUR AU - Karlsson, J. A. AU - Kristensen, L. E. AU - Kapetanovic, M. C. AU - Gulfe, A. AU - Saxne, T. AU - Geborek, P. PY - 2008 DA - 2008// TI - Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register JO - Rheumatology (Oxford) VL - 47 UR - https://doi.org/10.1093/rheumatology/ken034 DO - 10.1093/rheumatology/ken034 ID - Karlsson2008 ER - TY - JOUR AU - Lloyd, S. AU - Bujkiewicz, S. AU - Wailoo, A. J. AU - Sutton, A. J. AU - Scott, D. PY - 2010 DA - 2010// TI - The effectiveness of anti-TNF-{alpha} therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis JO - Rheumatology (Oxford) VL - 49 UR - https://doi.org/10.1093/rheumatology/keq169 DO - 10.1093/rheumatology/keq169 ID - Lloyd2010 ER - TY - JOUR AU - Hyrich, K. L. AU - Lunt, M. AU - Watson, K. D. AU - Symmons, D. P. AU - Silman, A. J. PY - 2007 DA - 2007// TI - Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study JO - Arthritis Rheum VL - 56 UR - https://doi.org/10.1002/art.22331 DO - 10.1002/art.22331 ID - Hyrich2007 ER - TY - JOUR AU - Gomez-Reino, J. J. AU - Carmona, L. PY - 2006 DA - 2006// TI - Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period JO - Arthritis Res Ther VL - 8 UR - https://doi.org/10.1186/ar1881 DO - 10.1186/ar1881 ID - Gomez-Reino2006 ER - TY - JOUR AU - Finckh, A. AU - Simard, J. F. AU - Gabay, C. AU - Guerne, P. A. PY - 2006 DA - 2006// TI - Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2005.045062 DO - 10.1136/ard.2005.045062 ID - Finckh2006 ER - TY - JOUR AU - Caporali, R. AU - Sarzi-Puttini, P. AU - Atzeni, F. AU - Gorla, R. AU - Filippini, M. AU - Marchesoni, A. AU - Favalli, E. G. AU - Bobbio-Pallavicini, F. AU - Montecucco, C. PY - 2010 DA - 2010// TI - Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry JO - Autoimmun Rev VL - 9 UR - https://doi.org/10.1016/j.autrev.2009.12.010 DO - 10.1016/j.autrev.2009.12.010 ID - Caporali2010 ER - TY - JOUR AU - Isaacs, J. D. PY - 2009 DA - 2009// TI - Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists JO - Expert Opin Biol Ther VL - 9 UR - https://doi.org/10.1517/14712590903379494 DO - 10.1517/14712590903379494 ID - Isaacs2009 ER - TY - JOUR AU - Cohen, S. B. AU - Emery, P. AU - Greenwald, M. W. AU - Dougados, M. AU - Furie, R. A. AU - Genovese, M. C. AU - Keystone, E. C. AU - Loveless, J. E. AU - Burmester, G. R. AU - Cravets, M. W. AU - Hessey, E. W. AU - Shaw, T. AU - Totoritis, M. C. PY - 2006 DA - 2006// TI - Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22025 DO - 10.1002/art.22025 ID - Cohen2006 ER - TY - JOUR AU - Genovese, M. C. AU - Schiff, M. AU - Luggen, M. AU - Becker, J. C. AU - Aranda, R. AU - Teng, J. AU - Li, T. AU - Schmidely, N. AU - Le, B. M. AU - Dougados, M. PY - 2008 DA - 2008// TI - Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.074773 DO - 10.1136/ard.2007.074773 ID - Genovese2008 ER - TY - JOUR AU - Genovese, M. C. AU - Becker, J. C. AU - Schiff, M. AU - Luggen, M. AU - Sherrer, Y. AU - Kremer, J. AU - Birbara, C. AU - Box, J. AU - Natarajan, K. AU - Nuamah, I. AU - Li, T. AU - Aranda, R. AU - Hagerty, D. T. AU - Dougados, M. PY - 2005 DA - 2005// TI - Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050524 DO - 10.1056/NEJMoa050524 ID - Genovese2005 ER - TY - JOUR AU - Emery, P. AU - Keystone, E. AU - Tony, H. P. AU - Cantagrel, A. AU - van, V. R. AU - Sanchez, A. AU - Alecock, E. AU - Lee, J. AU - Kremer, J. PY - 2008 DA - 2008// TI - IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2008.092932 DO - 10.1136/ard.2008.092932 ID - Emery2008 ER - TY - JOUR AU - Finckh, A. AU - Ciurea, A. AU - Brulhart, L. AU - Moller, B. AU - Walker, U. A. AU - Courvoisier, D. AU - Kyburz, D. AU - Dudler, J. AU - Gabay, C. PY - 2010 DA - 2010// TI - Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2008.105064 DO - 10.1136/ard.2008.105064 ID - Finckh2010 ER - TY - JOUR AU - Finckh, A. AU - Ciurea, A. AU - Brulhart, L. AU - Kyburz, D. AU - Moller, B. AU - Dehler, S. AU - Revaz, S. AU - Dudler, J. AU - Gabay, C. PY - 2007 DA - 2007// TI - B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents JO - Arthritis Rheum VL - 56 UR - https://doi.org/10.1002/art.22520 DO - 10.1002/art.22520 ID - Finckh2007 ER - TY - JOUR AU - Blom, M. AU - Kievit, W. AU - Fransen, J. AU - Kuper, I. H. AU - den Broeder, A. A. AU - De Gendt, C. M. AU - Jansen, T. L. AU - Brus, H. L. AU - van de Laar, M. A. AU - van Riel, P. L. PY - 2009 DA - 2009// TI - The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis JO - J Rheumatol VL - 36 UR - https://doi.org/10.3899/jrheum.090054 DO - 10.3899/jrheum.090054 ID - Blom2009 ER - TY - JOUR AU - Nair, K. V. AU - Tang, B. AU - Van Den, B. J. AU - Zhang, V. AU - Saseen, J. J. AU - Naim, A. AU - Rahman, M. PY - 2009 DA - 2009// TI - Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations JO - Curr Med Res Opin VL - 25 UR - https://doi.org/10.1185/03007990802598736 DO - 10.1185/03007990802598736 ID - Nair2009 ER - TY - JOUR AU - Blom, M. AU - Kievit, W. AU - Kuper, H. AU - Jansen, T. AU - Visser, H. AU - den Broeder, A. AU - Brus, H. AU - van de Laar, M. AU - van Riel, P. PY - 2010 DA - 2010// TI - The frequency and effectiveness of dose increase of adalimumab, etanercept and infliximab in daily clinical practice: results of the Dutch Rheumatoid Arthritis Monitoring registry JO - Arthritis Care Res (Hoboken) VL - 62 UR - https://doi.org/10.1002/acr.20211 DO - 10.1002/acr.20211 ID - Blom2010 ER - TY - JOUR AU - Tang, B. AU - Rahman, M. AU - Waters, H. C. AU - Callegari, P. PY - 2008 DA - 2008// TI - Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis JO - Clin Ther VL - 30 UR - https://doi.org/10.1016/S0149-2918(08)80063-X DO - 10.1016/S0149-2918(08)80063-X ID - Tang2008 ER - TY - JOUR AU - Hetland, M. L. AU - Christensen, I. J. AU - Tarp, U. AU - Dreyer, L. AU - Hansen, A. AU - Hansen, I. T. AU - Kollerup, G. AU - Linde, L. AU - Lindegaard, H. M. AU - Poulsen, U. E. AU - Schlemmer, A. AU - Jensen, D. V. AU - Jensen, S. AU - Hostenkamp, G. AU - Ostergaard, M. PY - 2010 DA - 2010// TI - Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry JO - Arthritis Rheum VL - 62 UR - https://doi.org/10.1002/art.27227 DO - 10.1002/art.27227 ID - Hetland2010 ER - TY - JOUR AU - Marchesoni, A. AU - Zaccara, E. AU - Gorla, R. AU - Bazzani, C. AU - Sarzi-Puttini, P. AU - Atzeni, F. AU - Caporali, R. AU - Bobbio-Pallavicini, F. AU - Favalli, E. G. PY - 2009 DA - 2009// TI - TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice JO - Ann N Y Acad Sci VL - 1173 UR - https://doi.org/10.1111/j.1749-6632.2009.04621.x DO - 10.1111/j.1749-6632.2009.04621.x ID - Marchesoni2009 ER - TY - CHAP PY - 2010 DA - 2010// BT - Enbrel prescribing information PB - Thousand Oaks CY - CA ID - ref40 ER - TY - CHAP PY - 2009 DA - 2009// BT - Humira prescribing information PB - North Chicago CY - IL ID - ref41 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/12/204/prepub UR - http://www.biomedcentral.com/1471-2474/12/204/prepub ID - ref42 ER -